A Clinical Trial To Study The Effect Of Oral administration Of Tab Kanchanar In Patient With Raktapradar

RANDOMIZED UNCONTROL CLINICAL TRIAL OF EFFICACY OF TAB KANCHANAR IN RAKTAPRADAR (MENORRHAGIA) DUE TO FIBROID. - NIL

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/12/077965

Enrollment

Registered

2024-12-11

Start date

Unknown

Completion date

Unknown

Last updated

2025-02-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N00-N99- Diseases of the genitourinary system

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patient willing to give informed written consent. 2.Patient having heavy menstrual bleeding with duration of bleeding more than 7 days or amount of bleeding more than 80ml or both at least 2 consecutive cycles.

Exclusion criteria

Exclusion criteria: 1. Patient having fibroid size more than 4cm. 2. Post menopausal bleeding. 3. Hb less than 7g/dL. 4. Patient using IUCD. 5. Pregnant women. 6. Patient having congenital anomalies.

Design outcomes

Primary

Measure	Time frame
To evaluate the efficacy of Tab Kanchanar in Raktapradar.Timepoint: 90 Days	—

Secondary

Measure	Time frame
To review Ayurvedic Concept of Raraktapradar according to different Acharyas. To review concept of uterine fibroid . To assess any untoward effects of Tab Kanchanar.Timepoint: 90 days	—

Countries

India

Contacts

Public ContactDr Radha Phadnis

Hon Shri Annasaheb Dange Ayurved Medica College Post Graduate and Research Center Ashta

radhakulkarni6@gmail.com9545114545

Outcome results